HNF1B and posterior cortical atrophy: The meta-analysis revealed that the elevated levels of HNF1B cell cycle signature were significantly associated with poor overall survival (P = 3.5e–03, lnHR: 0.85; 95% CI: 0.28–1.41) and biochemical recurrence (P = 6.1e–03, lnHR: 0.50; 95% CI: 0.14–0.85) in PCa patients.